This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline Intellectual Property Development Limited. Active years: 2021.
Company Filing History:
1 out of 545 
1 out of 242 
Years Active: 2021
Title: Catherine Cohet: Innovator in Immunogenic Compositions
Introduction
Catherine Cohet is a notable inventor based in Wavre, Belgium. She has made significant contributions to the field of immunology, particularly in the development of treatments for chronic obstructive pulmonary disease (COPD). Her work focuses on creating innovative solutions to improve patient outcomes.
Latest Patents
Catherine Cohet holds a patent for an immunogenic composition, which includes an immunogenic polypeptide and its fragments. This invention is aimed at treating or preventing the recurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) caused by bacterial infections. The patent highlights her commitment to advancing medical treatments and addressing critical health issues.
Career Highlights
Throughout her career, Catherine has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Catherine has collaborated with notable colleagues such as Jeanne-Marie Josephine Devaster and David Mayhew. These partnerships have enriched her work and facilitated the development of innovative solutions in immunology.
Conclusion
Catherine Cohet's contributions to the field of immunology through her patent and collaborations demonstrate her dedication to improving healthcare. Her innovative work continues to inspire advancements in the treatment of chronic diseases.